These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 9039879)

  • 1. Elevated glutamate in the cerebrospinal fluid of patients with HIV dementia.
    Ferrarese C; Riva R; Dolara A; De Micheli A; Frattola L
    JAMA; 1997 Feb; 277(8):630. PubMed ID: 9039879
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevated cerebrospinal fluid glutamate in patients with HIV-related dementia.
    Gurwitz D; Kloog Y
    JAMA; 1997 Jun; 277(24):1931. PubMed ID: 9200627
    [No Abstract]   [Full Text] [Related]  

  • 3. Glutamate may be the soluble cerebrospinal fluid factor that induces calcium dysregulation in cultured astrocytes in HIV dementia.
    Tremolizzo L; Aliprandi A; Longoni M; Stanzani L; Ferrarese C
    AIDS; 2002 Aug; 16(12):1691-2; author reply 1692-3. PubMed ID: 12172094
    [No Abstract]   [Full Text] [Related]  

  • 4. Relevance of glutamate levels in the CSF of patients with HIV-1-associated dementia complex.
    Espey MG; Ellis RJ; Heaton RK; Basile AS
    Neurology; 1999 Sep; 53(5):1144-5. PubMed ID: 10496286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased glutamate in CSF and plasma of patients with HIV dementia.
    Espey MG; Basile AS; Heaton RK; Ellis RJ
    Neurology; 2002 May; 58(9):1439; author reply 1439-40. PubMed ID: 12011305
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased glutamate in CSF and plasma of patients with HIV dementia.
    Ferrarese C; Aliprandi A; Tremolizzo L; Stanzani L; De Micheli A; Dolara A; Frattola L
    Neurology; 2001 Aug; 57(4):671-5. PubMed ID: 11524477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate metabolism and HIV-associated neurocognitive disorders.
    Vázquez-Santiago FJ; Noel RJ; Porter JT; Rivera-Amill V
    J Neurovirol; 2014 Aug; 20(4):315-31. PubMed ID: 24867611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status.
    Heyes MP; Brew BJ; Martin A; Price RW; Salazar AM; Sidtis JJ; Yergey JA; Mouradian MM; Sadler AE; Keilp J
    Ann Neurol; 1991 Feb; 29(2):202-9. PubMed ID: 1826418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of glutamate levels in HIV-infected subjects treated with acetylcarnitine.
    Famularo G; Moretti S; Alesse E; Trinchieri V; Angelucci A; Santini G; Cifone G; De Simone C
    J NeuroAIDS; 1999; 2(2):65-73. PubMed ID: 16873195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex.
    Jassoy C; Johnson RP; Navia BA; Worth J; Walker BD
    J Immunol; 1992 Nov; 149(9):3113-9. PubMed ID: 1383338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in AIDS dementia complex.
    Candito M; Durant J; Gurle V; Chambon P; Dellamonica P
    AIDS; 1995 Sep; 9(9):1100-1. PubMed ID: 8527086
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo evidence of HIV-1 productive infection in cerebrospinal fluid of patients with HIV-1 encephalopathy.
    Di Stefano M; Monno L; Ramon Fiore J; Angarano G
    AIDS; 1997 Apr; 11(5):698-9. PubMed ID: 9108963
    [No Abstract]   [Full Text] [Related]  

  • 13. Dual R3R5 tropism characterizes cerebrospinal fluid HIV-1 isolates from individuals with high cerebrospinal fluid viral load.
    Karlsson U; Antonsson L; Ljungberg B; Medstrand P; Esbjörnsson J; Jansson M; Gisslen M
    AIDS; 2012 Sep; 26(14):1739-44. PubMed ID: 22695299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta-1 and interferon-alpha in the AIDS dementia complex (ADC): possible relationship with cerebral viral load?
    Perrella O; Carreiri PB; Perrella A; Sbreglia C; Gorga F; Guarnaccia D; Tarantino G
    Eur Cytokine Netw; 2001 Mar; 12(1):51-5. PubMed ID: 11282546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia.
    Griffin DE; Wesselingh SL; McArthur JC
    Ann Neurol; 1994 May; 35(5):592-7. PubMed ID: 7910004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations.
    Cinque P; Nebuloni M; Santovito ML; Price RW; Gisslen M; Hagberg L; Bestetti A; Vago G; Lazzarin A; Blasi F; Sidenius N
    Ann Neurol; 2004 May; 55(5):687-94. PubMed ID: 15122709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential antibody markers in HIV-associated dementia.
    Schutzer SE; Berger JR; Brunner M
    J Neuroimmunol; 2004 Dec; 157(1-2):120-5. PubMed ID: 15579288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 RNA levels in cerebrospinal fluid and plasma correlate with AIDS dementia.
    Hengge UR; Brockmeyer NH; Esser S; Maschke M; Goos M
    AIDS; 1998 May; 12(7):818-20. PubMed ID: 9619817
    [No Abstract]   [Full Text] [Related]  

  • 19. Elevated levels of tumor necrosis factor (TNF) in the cerebrospinal fluid from patients with HIV-associated neurological disorders.
    Mastroianni CM; Paoletti F; Massetti AP; Falciano M; Vullo V
    Acta Neurol (Napoli); 1990 Feb; 12(1):66-7. PubMed ID: 2336997
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic and biological analysis of variants derived from the cerebrospinal fluid of HIV type 1 subtype B- and D- infected patients with and without AIDS dementia complex.
    Brengel-Pesce K; Morand P; Innocenti-Francillard P; Chanzy B; Bourgeat MJ; Leclercq P; Micoud M; Seigneurin JM
    AIDS Res Hum Retroviruses; 1996 Nov; 12(17):1643-5. PubMed ID: 8947301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.